EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Glymphatic Dysfunction in Hepatic Encephalopathy: A Novel Pathogenetic Pathway and Potential Target for New Therapeutic Opportunities

Efthymios-Leonidas Kaltsounis, Nikolaos Karakousis, George Pavlidis, Theodoros Androutsakos, Dimitrios S Karagiannakis

Journal of Gastrointestinal and Liver Diseases · 27.03.2026 · 35 (1) · 119-127

DOI: 10.15403/jgld-6636 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Gastrointestinal and Liver Diseases, online erschienen am 27.03.2026. Verfasst von Efthymios-Leonidas Kaltsounis und 4 weiteren Autor:innen. Beteiligte Einrichtung: 1st Department of Internal Medicine, Thriasio General Hospital of Eleusis, Athens, Greece. elkaltsounis@gmail.com. Hauptthemen laut MEDLINE: Hepatic Encephalopathy, Glymphatic System, Liver Cirrhosis. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatic encephalopathy (HE) is a common complication of decompensated liver cirrhosis and acute-on-chronic liver failure. It encompasses a range of symptoms, from minimal cognitive impairments to severe personality changes and even coma. Liver dysfunction, coupled with the development of portosystemic shunting (PSS), leads to the accumulation of toxic substances in the brain, adversely affecting its function. Common precipitating factors for HE include variceal bleeding, infections, and electrolyte imbalances. However, other mechanisms likely contribute to the onset of HE, as some patients experience episodes without identifiable predisposing factors. These patients may remain in a chronic state of latent HE or have increasingly frequent episodes of HE. One potential contributing factor to HE is dysfunction of the glymphatic system (GS), which clears metabolic waste from the brain. This review aims to highlight the mechanisms underlying GS dysfunction in individuals with liver cirrhosis and explore how it may relate to the development of HE. Additionally, it will provide information on therapeutic interventions that target glymphatic dysfunction, potentially offering new treatment options for HE in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatic EncephalopathyGlymphatic SystemLiver CirrhosisHumansAnimalsRisk Factors

Autor:innen und Institutionen

  • 1st Department of Internal Medicine, Thriasio General Hospital of Eleusis, Athens, Greece. elkaltsounis@gmail.com.
  • Department of Nutrition and Dietetics, School of Physical Education, Sport Sciences and Dietetics, University of Thessaly, Trikala, Greece. karak2727@gmail.com.
  • 4th Department of Internal Medicine, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. geo_pavlidis@yahoo.gr.
  • Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. t_androutsakos@yahoo.gr.
  • 4th Department of Internal Medicine, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. dkarag@med.uoa.gr.

Zitieren

APA

Kaltsounis, E. L., Karakousis, N., Pavlidis, G., Androutsakos, T., & Karagiannakis, D. S. (2026). Glymphatic Dysfunction in Hepatic Encephalopathy: A Novel Pathogenetic Pathway and Potential Target for New Therapeutic Opportunities. Journal of Gastrointestinal and Liver Diseases, 35(1), 119-127. https://doi.org/10.15403/jgld-6636

Vancouver

Kaltsounis EL, Karakousis N, Pavlidis G, Androutsakos T, Karagiannakis DS. Glymphatic Dysfunction in Hepatic Encephalopathy: A Novel Pathogenetic Pathway and Potential Target for New Therapeutic Opportunities. Journal of Gastrointestinal and Liver Diseases. 2026;35(1):119-127. doi:10.15403/jgld-6636

BibTeX
@article{Kaltsounis2026,
  author = {Kaltsounis, Efthymios-Leonidas and Karakousis, Nikolaos and Pavlidis, George and Androutsakos, Theodoros and Karagiannakis, Dimitrios S},
  title = {Glymphatic Dysfunction in Hepatic Encephalopathy: A Novel Pathogenetic Pathway and Potential Target for New Therapeutic Opportunities},
  journal = {Journal of Gastrointestinal and Liver Diseases},
  year = {2026},
  volume = {35},
  number = {1},
  pages = {119--127},
  doi = {10.15403/jgld-6636}
}
Kostenlos starten →